Article Details
Retrieved on: 2025-03-31 00:53:11
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Pfizer's new R&D center in Beijing to enhance drug development and integrate digital healthcare innovations. It connects to the key concept through China's strategic importance in the pharmaceutical industry, involving brands like Pfizer, AstraZeneca, and Medtronic.
Article found on: www.china.org.cn
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here